BiotechTube
Home/Syntax Bio/Andy May, DPhil
AM

Andy May, DPhil

Executive Chairman

Syntax Bio

Therapeutic Areas

Type 1 Diabetes

Syntax Bio Pipeline

DrugIndicationPhase
Pancreatic Beta Cell TherapyType 1 DiabetesPreclinical

Leadership Team at Syntax Bio

JC
John Craighead, PhD
CEO
RC
Ryan Clarke, PhD
Cofounder, CTO
BM
Brad Merrill, PhD
Cofounder, Head of Innovation
NB
Niko Balanis, PhD
Cofounder, VP Data Sci & Molecular Bio
NT
Nick Timmins, PhD
CSO
View full Syntax Bio profile